INM Insider Trading Activity and SEC Form 4 Filings
INM insider trading summary
Over the past 12 months, insiders at InMed Pharmaceuticals Inc. (INM) reported 158 open-market purchases worth $3.6M by 6 insiders and no sales on SEC Form 4. Net insider buying was $3.6M.
Latest INM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 23, 2026 | Daniel Schneeberger | 10% Owner | Buy | $5 (4 @ $1.32) |
| Oct 23, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | $5 (4 @ $1.32) |
| Oct 19, 2026 | Daniel Schneeberger | 10% Owner | Buy | $1K (1,086 @ $1.32) |
| Oct 19, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | $1K (1,086 @ $1.32) |
| Oct 16, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | $1 (1 @ $1.32) |
| Oct 16, 2026 | Daniel Schneeberger | 10% Owner | Buy | $1 (1 @ $1.32) |
| Oct 15, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | $1K (984 @ $1.32) |
| Oct 15, 2026 | Daniel Schneeberger | 10% Owner | Buy | $1K (984 @ $1.32) |
| Oct 14, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | $11K (8,021 @ $1.33) |
| Oct 14, 2026 | Daniel Schneeberger | 10% Owner | Buy | $11K (8,021 @ $1.33) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.